Systems and methods for pedal revascularization assessment

US10213122B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10213122-B2
Application numberUS-201715583746-A
CountryUS
Kind codeB2
Filing dateMay 1, 2017
Priority dateAug 15, 2012
Publication dateFeb 26, 2019
Grant dateFeb 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Diffuse optical flow (DOF) sensors can be used to assess deep tissue flow. DOF sensors positioned on a foot can provide fluctuating light intensity data to an analyzer, which can then determine absolute and/or relative blood flow. The determined absolute and/or relative blood flow can be signaled to an operator, for example a surgeon for intra-operative use. DOF sensors may be utilized to assess pedal revascularization, for example to guide interventional procedures and to evaluate their efficacy. A support structure can carry a plurality of DOF sensors, such that when the support structure is placed onto a patient's foot, the DOF sensors are disposed adjacent different locations on the foot. The different locations may correspond to different topographical regions of the foot, for example different pedal angiosomes.

First claim

Opening claim text (preview).

What is claimed is: 1. A system for assessment of peripheral blood flow characteristics in deep tissue, the system comprising: a support structure configured to be positioned onto an external body part of a patient; at least one diffuse optical flow (DOF) sensor carried by the support structure and configured to be positioned in optical communication with a skin surface of the patient, the at least one DOF sensor comprising a return optical conduit, and at least one input optical fiber comprising an end configured to be positioned proximate the skin surface of the patient, the at least one input optical fiber in optical communication with a coherent laser light source; a photodetector operably connected to the at least one DOF sensor; a processor configured to analyze data from the at least one DOF sensor to determine blood flow characteristics at a location near the at least one DOF sensor when the support structure is positioned onto the external body part of the patient, the processor configured to determine blood flow characteristics in blood vessels of the patient by determining a spatial speckle contrast ratio (K s ) or a temporal speckle contrast ratio (Kt) and determining 1/Ks 2 or 1/Kt 2 from intensity fluctuations, and correlating 1/Ks 2 or 1/Kt 2 values with blood flow; and a display configured to provide feedback indicative of the blood flow characteristics determined by the processor, wherein the at least one DOF sensor is configured to capture light scattered diffusively into tissue and transmitted at a depth of penetration of between 5 mm and 50 mm. 2. The system of claim 1 , wherein the support structure comprises a retention ring and an adhesive material. 3. The system of claim 1 , wherein the support structure comprises a strap having the at least one DOF sensor attached thereto. 4. The system of claim 1 , wherein the support structure comprises surgical tape. 5. The system of claim 1 , wherein the at least one DOF sensor comprises a plurality of DOF sensors, wherein the plurality of DOF sensors are arranged such that when the support structure is positioned onto the patient's external body part, at least two of the DOF sensors are over different topographical locations relating to different angiosomes of the patient. 6. The system of claim 5 , wherein the plurality of DOF sensors comprise at least four DOF sensors, wherein the at least four DOF sensors are arranged such that when the support structure is positioned over the patient's external body part, wherein the at least four DOF sensors are over different topographical locations relating to different angiosomes of the patient. 7. The system of claim 1 , wherein the processor is configured to provide the feedback indicative of the blood flow characteristics to the display in real-time. 8. The system of claim 1 , wherein processor is configured to provide the feedback indicative of the blood flow characteristics within 10 seconds from measurement. 9. A method for real-time assessment of peripheral blood flow characteristics, the method comprising: disposing at least one diffuse optical flow (DOF) sensor proximate a skin surface of a patient in optical communication with a first location on the patient, the at least one DOF sensor comprising a return optical conduit; transmitting light from a coherent laser light source through at least one input optical fiber of the at least one DOF sensor, the at least one input optical fiber comprising an end positioned proximate a second location on the patient; obtaining measurements at the first location of intensity fluctuation from a depth of penetration of between 5 mm and 50 mm within the patients microcirculatory channels from the at least one DOF sensor; analyzing the measurements obtained from the first location via a processor to determine blood flow characteristics, wherein analyzing comprises determining a spatial speckle contrast ratio (K s ) or a temporal speckle contrast ratio (Kt) and determining 1/Ks 2 or 1/Kt 2 from the intensity fluctuations, and correlating 1/Ks 2 or 1/K 2 values with blood flow; and signaling the determined blood flow characteristics to an operator. 10. The method of claim 9 , wherein disposing the at least one DOF sensor comprises placing a support structure onto the foot of the patient, the at least one DOF sensor being carried by the support structure. 11. The method of claim 9 , wherein disposing at least one DOF sensor comprises disposing a plurality of DOF sensors at a respective plurality of locations on the foot of the patient. 12. The method of claim 11 , wherein the plurality of locations comprises at least two locations corresponding to different topographical locations in the foot including different pedal angiosomes. 13. The method of claim 12 , wherein the plurality of locations comprises at least four locations corresponding to four different topographical locations in the foot including different pedal angiosomes. 14. The method of claim 9 , wherein the signaling comprises providing visual, audible, or tactile indicia of the determined blood flow characteristics. 15. A method for assessment of peripheral blood flow characteristics, the method comprising: disposing a plurality of diffuse optical flow (DOF) sensors each comprising a return optical conduit at a respective plurality of locations in optical communication with a skin surface of an extremity of a patient, wherein at least two of the plurality of locations correspond to different topographical locations in the patient including different angiosomes; transmitting light from a coherent laser light source through at least one input optical fiber of each of the plurality of DOF sensors, each of the at least one input optical fibers comprising an end positioned proximate the skin surface of the patient; determining blood flow characteristics at each of the plurality of locations in the extremity of the patient via a processor by analyzing detected scattered coherent light from depth of penetration of between 5 mm and 50 mm from within the patient's microcirculatory channels, wherein analyzing comprises determining a spatial speckle contrast ratio (K s ) or a temporal speckle contrast ratio (Kt) and determining 1/Ks2 or 1/K t 2 from intensity fluctuations, and correlating 1/Ks 2 or 1/Kt 2 values with blood flow; and signaling the determined blood flow characteristics to an operator. 16. The method of claim 15 , wherein the plurality of locations is on a foot of the patient. 17. The method of claim 15 , wherein the plurality of locations in on a hand of the patient. 18. The method of claim 15 , wherein the signaling is performed in real-time. 19. The method of claim 15 , further comprising utilizing the determined blood flow characteristics to assess the efficacy of a vascular interventional procedure.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10213122B2 cover?
Diffuse optical flow (DOF) sensors can be used to assess deep tissue flow. DOF sensors positioned on a foot can provide fluctuating light intensity data to an analyzer, which can then determine absolute and/or relative blood flow. The determined absolute and/or relative blood flow can be signaled to an operator, for example a surgeon for intra-operative use. DOF sensors may be utilized to asses…
Who is the assignee on this patent?
Univ Nanyang Tech
What technology area does this patent fall under?
Primary CPC classification A61B5/0261. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).